Investigative Urology - Results from #5340

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer - Abstract October 24, 2012

Expression of proton-coupled oligopeptide transporter (POTs) in prostate of mice and patients with benign prostatic hyperplasia (BPH) and prostate cancer (PCa) - Abstract October 24, 2012

PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer - Abstract October 24, 2012

Similarities and differences between effects of angiotensin III and angiotensin II on human prostate cancer cell migration and proliferation - Abstract October 24, 2012

Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A - Abstract October 24, 2012

Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression - Abstract October 24, 2012

Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells - Abstract October 24, 2012

Stromal expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of Decorin in prostate cancer - Abstract October 24, 2012

FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway - Abstract October 24, 2012

Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors - Abstract October 23, 2012

Characterizing prostate tumor mouse xenografts with CEST and MT-MRI and redox scanning - Abstract October 23, 2012

T cell profiling reveals high CD4(+)CTLA-4 (+) T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment - Abstract October 22, 2012

Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8(+) and CD4(+) T cells - Abstract October 22, 2012

PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation - Abstract October 22, 2012

Mechanosensitive Ca ( 2+) permeant cation channels in human prostate tumor cells - Abstract October 22, 2012

Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer - Abstract October 22, 2012

Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: Quantitative small-animal PET/CT and NIRF - Abstract October 22, 2012

Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells - Abstract October 22, 2012

Androgen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells - Abstract October 22, 2012

Plasma osteopontin as a biomarker of prostate cancer aggression: Relationship to risk category and treatment response - Abstract October 22, 2012

Page 268 of 346